CMPS · NASDAQ · Biotechnology

Compass Pathways (ADR) (CMPS)

Develops COMP360, an investigational psilocybin treatment with psychological support.

$14.83
After hours+0.05 (+0.37%)
At close$14.78(−1.57%)